Skip to content
healthcare.dev

Cystografin

NDC 0270-0149, diatrizoate meglumine, injection, solution, from BRACCO DIAGNOSTICS INC.

Product NDC
0270-0149
Status
Listed
Labeler
BRACCO DIAGNOSTICS INC
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA010040
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0270-0149 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DIATRIZOATE MEGLUMINE300 mg/mL

Pharmacologic classes

Radiographic Contrast Agent [EPC]; X-Ray Contrast Activity [MoA]

Package NDCNDC-11Package
0270-0149-570027001495710 BOTTLE in 1 PACKAGE (0270-0149-57) / 300 mL in 1 BOTTLE
0270-0149-600027001496010 BOTTLE in 1 PACKAGE (0270-0149-60) / 100 mL in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7496d736-9f7d-4136-ad5d-b24c7803c21b
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0270-0149

Use it

Look up 0270-0149 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0270-0149 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0270-0149. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.